Figure 8.
Effects of sorafenib (0.1–10 µM) on Ras activation in different human bladder carcinoma cell lines (RT4, T24, J82). Representative blots from three independent experiments are shown.
Effects of sorafenib (0.1–10 µM) on Ras activation in different human bladder carcinoma cell lines (RT4, T24, J82). Representative blots from three independent experiments are shown.